Source: Annual Congress 2005 - COPD - diagnosis and staging III



Rating:

Share or cite this content

Citations should be made in the following way:
M. Y. Klishina, E. S. Korotkova, O. V. Aleksandrov, S. P. Grigoriev, E. O. Loshkareva, M. V. Gurevich (Moscow, Russian Federation). Cardiointervalography in COPD patients with concomitant coronary heart disease. Eur Respir J 2005; 26: Suppl. 49, 3324

Member's Comments

No comment yet.

Related content which might interest you: Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002 COPD phenotypes not linked to increased risk of coronary heart disease Source: International Congress 2019 – Comorbidities galore in respiratory patients Year: 2019 Predictors of coronary heart disease in patients with COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Underappreciation of coronary artery disease in patients with COPD Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung Year: 2020 The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD treatment Year: 2013 COPD in heart failure patients Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD) Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Ischemic heart disease in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 706s Year: 2007 The frequency of combination of chronic obstructive pulmonary disease and coronary artery disease Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006 Lung diffusion capacity is reduced in patients with coronary artery disease and no signs of heart failure Source: Eur Respir J 2006; 28: Suppl. 50, 406s Year: 2006 The heart rate variability in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008 Ivabradine prevents salbutamol-induced disturbance of cardiac autonomic regulation in patients with chronic obstructive pulmonary disease and coronary heart disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Lipid profile in COPD patients with coronary artery disease comorbidity Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Cardiac effects of tiotropium bromide in patients with chronic obstructive pulmonary disease and coronary artery disease Source: Eur Respir J 2006; 28: Suppl. 50, 213s Year: 2006 Chronic obstructive pulmonary disease does not increase the risk of ischaemic heart disease Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Hypoxia as a risk factor for arrhythmias in patients with chronic obstructive pulmonary disease and heart failure Source: International Congress 2019 – More and more COPD Year: 2019 Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension Source: Annual Congress 2010 - COPD: management Year: 2010 Underestimation of bronchial obstruction in patients with coronary heart disease and cardiac insufficiency Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017 Heart failure and coronary artery disease in lung disease Source: International Congress 2018 – PG19 Heart-lung interaction Year: 2018